66.2 F
San Diego
Thursday, Oct 6, 2022
-Advertisement-

Proxy



NASDAQ , NUVA


NuVasive, Inc.

designs, develops and markets products for the surgical treatment of spine disorders. Its principal product offerings include a surgical platform called maximum access surgery and classic fusion products.

MAS platform allows surgeons to perform a range of minimally disruptive procedures, while overcoming the shortcomings of alternative minimally invasive surgical techniques. It combines NeuroVision, a nerve avoidance system, MaXcess, a minimally invasive surgical system, SpheRx Pedicle Screw System and specialized implants. The classic fusion portfolio includes a range of spine allografts and spine implants, such as rods, plates and screws.

Substantially, all of NuVasive’s products are distributed within the United States.


Value

- Advertisement -

Total number of shares outstanding as of July 29 24,100,000

Price of each share of common stock on July 29 $18.71

Aggregate market value as of July 29 $450,911,000


Performance Record

For year ended Dec. 31, in thousands, except per-share data.

2004 2003 2002

Total revenues $38,403 $22,655 $12,260

Net income (loss) ($14,210) ($10,127) ($15,110)

Net income (loss) per share ($0.91) ($6.30) ($13.20)

Total assets $80,752 $22,371 $14,932


Directors

Jack R. Blair, 62, director since 2001.

James C. Blair, 65, director since 1999.

Peter C. Farrell, 62, director since 2005.

Lesley H. Howe, 60, director since 2004.

Robert J. Hunt, 56, director since 2005.

Alexis V. Lukianov, 49, chairman since 2004.

Arda M. Minocherhomjee, 51, director since 2001.


Executive Compensation

Officer 2004 Cash Compensation

Alexis V. Lukianov, chief executive officer $519,762

Keith Valentine, president $330,183

Kevin C. O’Boyle, executive vice president, chief financial officer $292,500

Pat Miles, senior vice president, marketing $258,754

James J. Skinner, vice president, sales $224,135


Significant Stock Ownership

Number of shares Percent

March 31

William Blair Capital Partners VII QP, L.P. 2,833,880 11.8

Arda M. Minocherhomjee 2,833,880 11.8

Caisse de depot et placement du Quebec 2,024,941 8.4

Kleiner Perkins Caufield & Byers VIII, L.P. 1,859,581 7.7

Joseph S. Lacob 1,859,581 7.7

Domain Partners IV, L.P. 1,821,659 7.6

Directors and officers as a group (14 people) 8,770,033 36.5


Other Information

Headquarters: 4545 Towne Centre Court, San Diego, CA 92121; (858) 271-7070;

fax (858) 909-2000.

Web site: www.nuvasive.com.

Auditors: Ernst & Young LLP.

Employees: 105.

Industry: Medical instruments and supplies.

Information was compiled from the company’s annual and proxy reports.

-Advertisement-

Featured Articles

-Advertisement-
-Advertisement-

Related Articles

-Advertisement-
-Advertisement-
-Advertisement-